Kuwait vs Sweden: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Kuwait
95.0%
in 2025
Sweden
95.0%
in 2025
Kuwait rank
38th
Sweden rank
38th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Kuwait
- Sweden
How they compare
Kuwait currently reports 95.0% against 95.0% in Sweden, a difference of 0.0%.
The two have swapped places 7 times across 18 shared years of data; in 2008 it was Kuwait ahead.
Kuwait ranks 38th and Sweden ranks 38th of 194 countries.
Across the 3 decades both report, Kuwait averaged higher in 2 and Sweden in 1.
Head to head by decade
| Decade | Kuwait | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 99.0% | 79.0% | 20.0% | Kuwait |
| 2010s | 97.0% | 97.5% | 0.5% | Sweden |
| 2020s | 96.5% | 95.2% | 1.3% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Kuwait or Sweden?
- Kuwait, at 95.0% against 95.0% in Sweden as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Kuwait and Sweden?
- 0.0%, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Sweden?
- 18 years are reported by both, from 2008 to 2025.
- How do Kuwait and Sweden rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Kuwait ranks 38th and Sweden ranks 38th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.